NCJ Number
311074
Date Published
May 2025
Abstract
BTMPS has been detected in all regions across the United States, demonstrating vast prevalence. BTMPS has appeared in more than 600 drug materials tested by our laboratory. Tetramethyl-4-piperidinol (TMP) was first detected in August 2024 and since has appeared in more than 20 drug materials. Tetramethyl-4-AP (TM-4-AP) and tetramethylnorfentanyl (TMNF) were first detected in April 2025 and since have appeared in more than ten drug materials, often together. To date, a substance suspected of being tetramethylfentanyl (TMF) has been identified in only small (or trace) amounts alongside these other related substances; however, confirmation of this substance is pending acquisition of standard reference material.
(Publisher abstract provided.)
Date Published: May 1, 2025
Downloads
Similar Publications
- Sex Trafficking Red Flags: Confirming Presentation Patterns and Childhood Adversity Risk Factors
- Cumulative Bullying Experiences, Adolescent Behavioral and Mental Health, and Academic Achievement: An Integrative Model of Perpetration, Victimization, and Bystander Behavior
- Forensic Applicability of Femur Subtrochanteric Shape to Ancestry Assessment in Thai and White American Males